peter dines, investment director and head of life sciences, mercia, at "journeys of health-tech...

16
PETER DINES Life Science Fundraising

Upload: healthtechinnovationlabs

Post on 19-Jan-2017

809 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

PETER DINES Life Science Fundraising

Page 2: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

What do Investors look for?

Mercia Technologies 2016

• Who am I and what is Mercia?

• What to focus on and what not to do?

Page 3: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

The Complete Capital Model

Mercia Technologies 2016

Who am I?

Page 4: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

6Mercia Technologies 2016

Mercia Technologies’ is a leading player in the creation, funding and development of high growth technology businesses

throughout the UK, focused on:

Sector Focus

Regional Focus

Complete Capital

SolutionBuild & Delivery

Mercia Focus

Page 5: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Investment Approach

£10k

to £150k

£80k

to £1m

£0.5m

to £2m

£1m

to £5m

Scale

Exit

MFM

MFM

Mercia

Technologies

Mercia

Technologies

Review and proactively seek companies in four core areas of focus

Business criteria

Perform due diligence

Determine whether to invest

Provide:

Infrastructure

Incubator and management

support

Flexible capital

Accelerate development & growthFast-track investment in best businesses

Strengthen the organisation to embrace scale

Grow customer base and partnerships

Accelerate value creation

Exit at most beneficial point

Pathfinder

& Seed

Early stage &

Development

Mercia Technologies 2016

Page 6: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Mercia Technologies 2016 12

Investment Model

NEW AHSN FUND

Page 7: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Mercia Technologies 2016

What is your core technology?

• USP• Intellectual Property• Barriers to entry

Page 8: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Mercia Technologies 2015

What is the market opportunity?

• Addressable market ££• Competition• Route to market

• Reimbursement• Regulatory

Page 9: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Mercia Technologies 2015

• Management• Management• Management

Page 10: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Importance of Leadership

Mercia Technologies 2015

*** PATRICK LENCIONI - Mandatory reading for all leaders and entrepreneurs!!!

Page 11: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

What are you going to measure?

Mercia Technologies 2015

SALES

EBITDA

CASH FLOW

CUSTOMER EXPERIENCE

YOU CAN’T MANAGE WHAT YOU DON’T MEASURE

Product Development

Milestones

SALES PIPELINE

CUSTOMER SATISFACTIONOther KPI’s

Page 12: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Optimist vs Healthy Cynic!!

Mercia Technologies 2015

§

Page 13: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

What is the funding requirement?

Mercia Technologies 2016

Page 14: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

What is the likely exit?

Mercia Technologies 2016

• IPO• Trade Sale• Who is likely acquirer?• What are the returns?

Page 15: Peter Dines, Investment Director and Head of Life Sciences, Mercia, at "Journeys of Health-Tech Innovation", March 22nd 2016

Funding Options?

Mercia Technologies 2016

• Friends and Family• Grants• Regional/European Funding• Angel Investment• Investment Company

(EIS/VCT)• Corporate Investor